Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannGros is a Danish pharmaceutical distributor specializing in medical cannabis products and is a subsidiary of Little Green Pharma. Founded in 2017 to support the Danish medical cannabis pilot program, the company was the first to receive a license for the import and distribution of medicinal cannabis in Denmark. CannGros serves as a primary distributor for standardized cannabis products, including the Bedrocan range and Little Green Pharma's own portfolio. The company focuses on providing pharmaceutical-grade cannabis flowers and oils to pharmacies and hospitals, ensuring patient access to regulated treatments for conditions like chronic pain and multiple sclerosis. Their operations are strictly governed by the Danish Medicines Agency's regulations and focus on maintaining a reliable supply chain for the Danish market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannGros.